ଟାଭାବୋରୋଲ

ଟାଭାବୋରୋଲ
Clinical data
Trade names	Kerydin
Synonyms	AN2690
AHFS/Drugs.com	monograph
MedlinePlus	a614049
Pregnancy; category	US: N (Not classified yet) ; ;
Routes of; administration	Topical
Legal status
Legal status	US: ℞-only ; ℞ (Prescription only);
Identifiers
	IUPAC name 5-Fluoro-2,1-benzoxaborol-1(3H)-ol;
ECHA InfoCard	100.218.130
Chemical and physical data
Formula	C7H6BFO2
Molar mass	୧୫୧.୯୩ g·mol−1
3D model (JSmol)	Interactive image;
	SMILES B1(C2=C(CO1)C=C(C=C2)F)O;
	InChI InChI=1S/C7H6BFO2/c9-6-1-2-7-5(3-6)4-11-8(7)10/h1-3,10H,4H2; Key:LFQDNHWZDQTITF-UHFFFAOYSA-N;

ଇଂରାଜୀ ଲିଙ୍କ

https://or.wikipedia.org/wiki/Tavaborole

ଟାଭାବୋରୋଲ (ଇଂରାଜୀ ଭାଷାରେ Tavaborole), କେରିଡିନ ବ୍ରାଣ୍ଡ ଏହାର ଏକ ବେପାର ନାମ, ହେଉଛି ଏକ କବକରୋଧୀ ଔଷଧ ଯାହା ନଖରରେ ହେଉଥିବା କବକ ସଂକ୍ରମଣର ଚିକିତ୍ସା ପାଇଁ ବ୍ୟବହୃତ ହୁଏ ।^[୧] ଏହାକୁ ନଖରେ ପ୍ରୟୋଗ କରି ବ୍ୟବହୃତ ହୁଏ ।^[୧] ସାମାନ୍ୟରୁ ମଧ୍ୟମ ରୋଗରେ ଏହାକୁ ବ୍ୟବହାର କରାଯାଏ ।^[୨]

ପାର୍ଶ୍ୱ ପ୍ରତିକ୍ରିୟାରେ ଚର୍ମର ଉତ୍ତେଜନା ଏବଂ ଏକ ଅନ୍ତର୍ବଦ୍ଧିତ ନ‌ଖ ହୋଇପାରେ ।^[୧] ଏହା ଏକ ଲିଉସିଲ-ଟିଆରଏନଏ ସିନ୍ଥେଟେଜ ନାମକ ଏଞ୍ଜାଇମକୁ ପ୍ରତିରୋଧ କରି କାର୍ଯ୍ୟକ୍ଷମ ହୁଏ ଯାହା ଫଙ୍ଗସ୍ ପ୍ରୋଟିନ୍ ତିଆରି କରିବା ପାଇଁ ଆବଶ୍ୟକ ହୁଏ ।^[୧]

୨୦୧୪ ମସିହାରେ ଯୁକ୍ତରାଷ୍ଟ୍ରରେ ଚିକିତ୍ସା ବ୍ୟବହାର ପାଇଁ ଟାଭାବୋରୋଲକୁ ଅନୁମୋଦନ କରାଯାଇଥିଲା ।^[୩] ଯୁକ୍ତରାଷ୍ଟ୍ରରେ ୨୦୨୧ ସୁଦ୍ଧା ୧୦ ମିମି ଦ୍ରବଣର ମୂଲ୍ୟ ପ୍ରାୟ ୧୬୦୦ ଡଲାର ଅଟେ ।^[୪] ଏହା କାନାଡାରେ ମଧ୍ୟ ଉପଲବ୍ଧ କିନ୍ତୁ ୨୦୧୮ ସୁଦ୍ଧା ୟୁରୋପରେ ଉପଲବ୍ଧ ହୋଇ ନଥିଲା ।^[୫]

ଆଧାର

↑ ^୧.୦ ^୧.୧ ^୧.୨ ^୧.୩ "Tavaborole Monograph for Professionals". Drugs.com (in ଇଂରାଜୀ). Archived from the original on 21 May 2016. Retrieved 23 September 2021.
↑ Jinna, S; Finch, J (2015). "Spotlight on tavaborole for the treatment of onychomycosis". Drug design, development and therapy. 9: 6185–90. doi:10.2147/DDDT.S81944. PMID 26640371.{{cite journal}}: CS1 maint: unflagged free DOI (link)
↑ Gupta, Aditya K.; Mays, Rachel R.; Folley, Kelly A. (2019). "42. Topical antifungal agents". In Wolverton, Stephen E.; Wu, Jashin J. (eds.). Comprehensive Dermatologic Drug Therapy (in ଇଂରାଜୀ) (4th ed.). Elsevier. p. 488. ISBN 978-0-323-61211-1. Archived from the original on 2021-10-09. Retrieved 2021-10-07.
↑ "Kerydin Prices, Coupons & Patient Assistance Programs". Drugs.com (in ଇଂରାଜୀ). Archived from the original on 15 January 2021. Retrieved 23 September 2021.
↑ Rigopoulos, Dimitris; Elewski, Boni; Richert, Bertrand (6 August 2018). Onychomycosis: Diagnosis and Effective Management (in ଇଂରାଜୀ). John Wiley & Sons. p. 105. ISBN 978-1-119-22653-6. Archived from the original on 23 September 2021. Retrieved 23 September 2021.

[AHFS2021-1] ୧.୦ ^୧.୧ ^୧.୨ ^୧.୩ "Tavaborole Monograph for Professionals". Drugs.com (in ଇଂରାଜୀ). Archived from the original on 21 May 2016. Retrieved 23 September 2021.

[2] Jinna, S; Finch, J (2015). "Spotlight on tavaborole for the treatment of onychomycosis". Drug design, development and therapy. 9: 6185–90. doi:10.2147/DDDT.S81944. PMID 26640371.{{cite journal}}: CS1 maint: unflagged free DOI (link)

[Wolverton2019-3] Gupta, Aditya K.; Mays, Rachel R.; Folley, Kelly A. (2019). "42. Topical antifungal agents". In Wolverton, Stephen E.; Wu, Jashin J. (eds.). Comprehensive Dermatologic Drug Therapy (in ଇଂରାଜୀ) (4th ed.). Elsevier. p. 488. ISBN 978-0-323-61211-1. Archived from the original on 2021-10-09. Retrieved 2021-10-07.

[4] "Kerydin Prices, Coupons & Patient Assistance Programs". Drugs.com (in ଇଂରାଜୀ). Archived from the original on 15 January 2021. Retrieved 23 September 2021.

[5] Rigopoulos, Dimitris; Elewski, Boni; Richert, Bertrand (6 August 2018). Onychomycosis: Diagnosis and Effective Management (in ଇଂରାଜୀ). John Wiley & Sons. p. 105. ISBN 978-1-119-22653-6. Archived from the original on 23 September 2021. Retrieved 23 September 2021.

[୧]

[୨]

[୩]

[୪]

[୫]